Global Monoclonal Antibodies Market Growth 2025-2031

October 2025 | 89 pages | ID: G05C578A0D38EN
LP Information

Abstracts

The global Monoclonal Antibodies market size is predicted to grow from US$ 117600 million in 2025 to US$ 154260 million in 2031; it is expected to grow at a CAGR of 4.6% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Monoclonal antibody therapeutics is a type of immunotherapy in which monoclonal antibodies are used so that they can bind monospecifically to specific cells and proteins.

This treatment stimulates the immune system of patients to attack the foreign cells which cause the disease. Monoclonal antibodies are produced by using hybridoma technology. In hybridoma technology, the antibodies are obtained by fusion of human spleen cells and human myeloma. The characteristics of monoclonal antibodies which affect their efficacy are antigen specificity, overall structure and the affinity of the antibody for the target antigen or cells.

LP Information, Inc. (LPI) ' newest research report, the ?Monoclonal Antibodies Industry Forecast? looks at past sales and reviews total world Monoclonal Antibodies sales in 2024, providing a comprehensive analysis by region and market sector of projected Monoclonal Antibodies sales for 2025 through 2031. With Monoclonal Antibodies sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Monoclonal Antibodies industry.

This Insight Report provides a comprehensive analysis of the global Monoclonal Antibodies landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Monoclonal Antibodies portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Monoclonal Antibodies market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Monoclonal Antibodies and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Monoclonal Antibodies.

This report presents a comprehensive overview, market shares, and growth opportunities of Monoclonal Antibodies market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Erythropoietin (EPO)
• Human Growth Hormone (HGH)
• Granulocyte- Colony Stimulating Factor (G-CSF)
• Monoclonal Antibody (mAb)
• Insulin
• Interferon (IFN)
• Others

Segmentation by Application:

• Anti-Cancer
• Anti-Inflammatory/Autoimmune

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Biocon
• Celltrion
• Dr. Reddy's Laboratories
• Hospira
• 3SBio
• Accord Healthcare
• AET Biotech
• Allergan
• Amega Biotech

Key Questions Addressed in this Report

What is the 10-year outlook for the global Monoclonal Antibodies market?
What factors are driving Monoclonal Antibodies market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Monoclonal Antibodies market opportunities vary by end market size?
How does Monoclonal Antibodies break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Monoclonal Antibodies Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Monoclonal Antibodies by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Monoclonal Antibodies by Country/Region, 2020, 2024 & 2031
2.2 Monoclonal Antibodies Segment by Type
  2.2.1 Erythropoietin (EPO)
  2.2.2 Human Growth Hormone (HGH)
  2.2.3 Granulocyte- Colony Stimulating Factor (G-CSF)
  2.2.4 Monoclonal Antibody (mAb)
  2.2.5 Insulin
  2.2.6 Interferon (IFN)
  2.2.7 Others
2.3 Monoclonal Antibodies Sales by Type
  2.3.1 Global Monoclonal Antibodies Sales Market Share by Type (2020-2025)
  2.3.2 Global Monoclonal Antibodies Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Monoclonal Antibodies Sale Price by Type (2020-2025)
2.4 Monoclonal Antibodies Segment by Application
  2.4.1 Anti-Cancer
  2.4.2 Anti-Inflammatory/Autoimmune
2.5 Monoclonal Antibodies Sales by Application
  2.5.1 Global Monoclonal Antibodies Sale Market Share by Application (2020-2025)
  2.5.2 Global Monoclonal Antibodies Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Monoclonal Antibodies Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Monoclonal Antibodies Breakdown Data by Company
  3.1.1 Global Monoclonal Antibodies Annual Sales by Company (2020-2025)
  3.1.2 Global Monoclonal Antibodies Sales Market Share by Company (2020-2025)
3.2 Global Monoclonal Antibodies Annual Revenue by Company (2020-2025)
  3.2.1 Global Monoclonal Antibodies Revenue by Company (2020-2025)
  3.2.2 Global Monoclonal Antibodies Revenue Market Share by Company (2020-2025)
3.3 Global Monoclonal Antibodies Sale Price by Company
3.4 Key Manufacturers Monoclonal Antibodies Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Monoclonal Antibodies Product Location Distribution
  3.4.2 Players Monoclonal Antibodies Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR MONOCLONAL ANTIBODIES BY GEOGRAPHIC REGION

4.1 World Historic Monoclonal Antibodies Market Size by Geographic Region (2020-2025)
  4.1.1 Global Monoclonal Antibodies Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Monoclonal Antibodies Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Monoclonal Antibodies Market Size by Country/Region (2020-2025)
  4.2.1 Global Monoclonal Antibodies Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Monoclonal Antibodies Annual Revenue by Country/Region (2020-2025)
4.3 Americas Monoclonal Antibodies Sales Growth
4.4 APAC Monoclonal Antibodies Sales Growth
4.5 Europe Monoclonal Antibodies Sales Growth
4.6 Middle East & Africa Monoclonal Antibodies Sales Growth

5 AMERICAS

5.1 Americas Monoclonal Antibodies Sales by Country
  5.1.1 Americas Monoclonal Antibodies Sales by Country (2020-2025)
  5.1.2 Americas Monoclonal Antibodies Revenue by Country (2020-2025)
5.2 Americas Monoclonal Antibodies Sales by Type (2020-2025)
5.3 Americas Monoclonal Antibodies Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Monoclonal Antibodies Sales by Region
  6.1.1 APAC Monoclonal Antibodies Sales by Region (2020-2025)
  6.1.2 APAC Monoclonal Antibodies Revenue by Region (2020-2025)
6.2 APAC Monoclonal Antibodies Sales by Type (2020-2025)
6.3 APAC Monoclonal Antibodies Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Monoclonal Antibodies by Country
  7.1.1 Europe Monoclonal Antibodies Sales by Country (2020-2025)
  7.1.2 Europe Monoclonal Antibodies Revenue by Country (2020-2025)
7.2 Europe Monoclonal Antibodies Sales by Type (2020-2025)
7.3 Europe Monoclonal Antibodies Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Monoclonal Antibodies by Country
  8.1.1 Middle East & Africa Monoclonal Antibodies Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Monoclonal Antibodies Revenue by Country (2020-2025)
8.2 Middle East & Africa Monoclonal Antibodies Sales by Type (2020-2025)
8.3 Middle East & Africa Monoclonal Antibodies Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Monoclonal Antibodies
10.3 Manufacturing Process Analysis of Monoclonal Antibodies
10.4 Industry Chain Structure of Monoclonal Antibodies

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Monoclonal Antibodies Distributors
11.3 Monoclonal Antibodies Customer

12 WORLD FORECAST REVIEW FOR MONOCLONAL ANTIBODIES BY GEOGRAPHIC REGION

12.1 Global Monoclonal Antibodies Market Size Forecast by Region
  12.1.1 Global Monoclonal Antibodies Forecast by Region (2026-2031)
  12.1.2 Global Monoclonal Antibodies Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Monoclonal Antibodies Forecast by Type (2026-2031)
12.7 Global Monoclonal Antibodies Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Biocon
  13.1.1 Biocon Company Information
  13.1.2 Biocon Monoclonal Antibodies Product Portfolios and Specifications
  13.1.3 Biocon Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Biocon Main Business Overview
  13.1.5 Biocon Latest Developments
13.2 Celltrion
  13.2.1 Celltrion Company Information
  13.2.2 Celltrion Monoclonal Antibodies Product Portfolios and Specifications
  13.2.3 Celltrion Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Celltrion Main Business Overview
  13.2.5 Celltrion Latest Developments
13.3 Dr. Reddy's Laboratories
  13.3.1 Dr. Reddy's Laboratories Company Information
  13.3.2 Dr. Reddy's Laboratories Monoclonal Antibodies Product Portfolios and Specifications
  13.3.3 Dr. Reddy's Laboratories Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Dr. Reddy's Laboratories Main Business Overview
  13.3.5 Dr. Reddy's Laboratories Latest Developments
13.4 Hospira
  13.4.1 Hospira Company Information
  13.4.2 Hospira Monoclonal Antibodies Product Portfolios and Specifications
  13.4.3 Hospira Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Hospira Main Business Overview
  13.4.5 Hospira Latest Developments
13.5 3SBio
  13.5.1 3SBio Company Information
  13.5.2 3SBio Monoclonal Antibodies Product Portfolios and Specifications
  13.5.3 3SBio Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 3SBio Main Business Overview
  13.5.5 3SBio Latest Developments
13.6 Accord Healthcare
  13.6.1 Accord Healthcare Company Information
  13.6.2 Accord Healthcare Monoclonal Antibodies Product Portfolios and Specifications
  13.6.3 Accord Healthcare Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Accord Healthcare Main Business Overview
  13.6.5 Accord Healthcare Latest Developments
13.7 AET Biotech
  13.7.1 AET Biotech Company Information
  13.7.2 AET Biotech Monoclonal Antibodies Product Portfolios and Specifications
  13.7.3 AET Biotech Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 AET Biotech Main Business Overview
  13.7.5 AET Biotech Latest Developments
13.8 Allergan
  13.8.1 Allergan Company Information
  13.8.2 Allergan Monoclonal Antibodies Product Portfolios and Specifications
  13.8.3 Allergan Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 Allergan Main Business Overview
  13.8.5 Allergan Latest Developments
13.9 Amega Biotech
  13.9.1 Amega Biotech Company Information
  13.9.2 Amega Biotech Monoclonal Antibodies Product Portfolios and Specifications
  13.9.3 Amega Biotech Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2020-2025)
  13.9.4 Amega Biotech Main Business Overview
  13.9.5 Amega Biotech Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Monoclonal Antibodies Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Monoclonal Antibodies Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Erythropoietin (EPO)
Table 4. Major Players of Human Growth Hormone (HGH)
Table 5. Major Players of Granulocyte- Colony Stimulating Factor (G-CSF)
Table 6. Major Players of Monoclonal Antibody (mAb)
Table 7. Major Players of Insulin
Table 8. Major Players of Interferon (IFN)
Table 9. Major Players of Others
Table 10. Global Monoclonal Antibodies Sales by Type (2020-2025) & (Units)
Table 11. Global Monoclonal Antibodies Sales Market Share by Type (2020-2025)
Table 12. Global Monoclonal Antibodies Revenue by Type (2020-2025) & ($ million)
Table 13. Global Monoclonal Antibodies Revenue Market Share by Type (2020-2025)
Table 14. Global Monoclonal Antibodies Sale Price by Type (2020-2025) & (USD/Unit)
Table 15. Global Monoclonal Antibodies Sale by Application (2020-2025) & (Units)
Table 16. Global Monoclonal Antibodies Sale Market Share by Application (2020-2025)
Table 17. Global Monoclonal Antibodies Revenue by Application (2020-2025) & ($ million)
Table 18. Global Monoclonal Antibodies Revenue Market Share by Application (2020-2025)
Table 19. Global Monoclonal Antibodies Sale Price by Application (2020-2025) & (USD/Unit)
Table 20. Global Monoclonal Antibodies Sales by Company (2020-2025) & (Units)
Table 21. Global Monoclonal Antibodies Sales Market Share by Company (2020-2025)
Table 22. Global Monoclonal Antibodies Revenue by Company (2020-2025) & ($ millions)
Table 23. Global Monoclonal Antibodies Revenue Market Share by Company (2020-2025)
Table 24. Global Monoclonal Antibodies Sale Price by Company (2020-2025) & (USD/Unit)
Table 25. Key Manufacturers Monoclonal Antibodies Producing Area Distribution and Sales Area
Table 26. Players Monoclonal Antibodies Products Offered
Table 27. Monoclonal Antibodies Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 28. New Products and Potential Entrants
Table 29. Market M&A Activity & Strategy
Table 30. Global Monoclonal Antibodies Sales by Geographic Region (2020-2025) & (Units)
Table 31. Global Monoclonal Antibodies Sales Market Share Geographic Region (2020-2025)
Table 32. Global Monoclonal Antibodies Revenue by Geographic Region (2020-2025) & ($ millions)
Table 33. Global Monoclonal Antibodies Revenue Market Share by Geographic Region (2020-2025)
Table 34. Global Monoclonal Antibodies Sales by Country/Region (2020-2025) & (Units)
Table 35. Global Monoclonal Antibodies Sales Market Share by Country/Region (2020-2025)
Table 36. Global Monoclonal Antibodies Revenue by Country/Region (2020-2025) & ($ millions)
Table 37. Global Monoclonal Antibodies Revenue Market Share by Country/Region (2020-2025)
Table 38. Americas Monoclonal Antibodies Sales by Country (2020-2025) & (Units)
Table 39. Americas Monoclonal Antibodies Sales Market Share by Country (2020-2025)
Table 40. Americas Monoclonal Antibodies Revenue by Country (2020-2025) & ($ millions)
Table 41. Americas Monoclonal Antibodies Sales by Type (2020-2025) & (Units)
Table 42. Americas Monoclonal Antibodies Sales by Application (2020-2025) & (Units)
Table 43. APAC Monoclonal Antibodies Sales by Region (2020-2025) & (Units)
Table 44. APAC Monoclonal Antibodies Sales Market Share by Region (2020-2025)
Table 45. APAC Monoclonal Antibodies Revenue by Region (2020-2025) & ($ millions)
Table 46. APAC Monoclonal Antibodies Sales by Type (2020-2025) & (Units)
Table 47. APAC Monoclonal Antibodies Sales by Application (2020-2025) & (Units)
Table 48. Europe Monoclonal Antibodies Sales by Country (2020-2025) & (Units)
Table 49. Europe Monoclonal Antibodies Revenue by Country (2020-2025) & ($ millions)
Table 50. Europe Monoclonal Antibodies Sales by Type (2020-2025) & (Units)
Table 51. Europe Monoclonal Antibodies Sales by Application (2020-2025) & (Units)
Table 52. Middle East & Africa Monoclonal Antibodies Sales by Country (2020-2025) & (Units)
Table 53. Middle East & Africa Monoclonal Antibodies Revenue Market Share by Country (2020-2025)
Table 54. Middle East & Africa Monoclonal Antibodies Sales by Type (2020-2025) & (Units)
Table 55. Middle East & Africa Monoclonal Antibodies Sales by Application (2020-2025) & (Units)
Table 56. Key Market Drivers & Growth Opportunities of Monoclonal Antibodies
Table 57. Key Market Challenges & Risks of Monoclonal Antibodies
Table 58. Key Industry Trends of Monoclonal Antibodies
Table 59. Monoclonal Antibodies Raw Material
Table 60. Key Suppliers of Raw Materials
Table 61. Monoclonal Antibodies Distributors List
Table 62. Monoclonal Antibodies Customer List
Table 63. Global Monoclonal Antibodies Sales Forecast by Region (2026-2031) & (Units)
Table 64. Global Monoclonal Antibodies Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Americas Monoclonal Antibodies Sales Forecast by Country (2026-2031) & (Units)
Table 66. Americas Monoclonal Antibodies Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. APAC Monoclonal Antibodies Sales Forecast by Region (2026-2031) & (Units)
Table 68. APAC Monoclonal Antibodies Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 69. Europe Monoclonal Antibodies Sales Forecast by Country (2026-2031) & (Units)
Table 70. Europe Monoclonal Antibodies Revenue Forecast by Country (2026-2031) & ($ millions)
Table 71. Middle East & Africa Monoclonal Antibodies Sales Forecast by Country (2026-2031) & (Units)
Table 72. Middle East & Africa Monoclonal Antibodies Revenue Forecast by Country (2026-2031) & ($ millions)
Table 73. Global Monoclonal Antibodies Sales Forecast by Type (2026-2031) & (Units)
Table 74. Global Monoclonal Antibodies Revenue Forecast by Type (2026-2031) & ($ millions)
Table 75. Global Monoclonal Antibodies Sales Forecast by Application (2026-2031) & (Units)
Table 76. Global Monoclonal Antibodies Revenue Forecast by Application (2026-2031) & ($ millions)
Table 77. Biocon Basic Information, Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors
Table 78. Biocon Monoclonal Antibodies Product Portfolios and Specifications
Table 79. Biocon Monoclonal Antibodies Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Biocon Main Business
Table 81. Biocon Latest Developments
Table 82. Celltrion Basic Information, Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors
Table 83. Celltrion Monoclonal Antibodies Product Portfolios and Specifications
Table 84. Celltrion Monoclonal Antibodies Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Celltrion Main Business
Table 86. Celltrion Latest Developments
Table 87. Dr. Reddy's Laboratories Basic Information, Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors
Table 88. Dr. Reddy's Laboratories Monoclonal Antibodies Product Portfolios and Specifications
Table 89. Dr. Reddy's Laboratories Monoclonal Antibodies Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Dr. Reddy's Laboratories Main Business
Table 91. Dr. Reddy's Laboratories Latest Developments
Table 92. Hospira Basic Information, Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors
Table 93. Hospira Monoclonal Antibodies Product Portfolios and Specifications
Table 94. Hospira Monoclonal Antibodies Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. Hospira Main Business
Table 96. Hospira Latest Developments
Table 97. 3SBio Basic Information, Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors
Table 98. 3SBio Monoclonal Antibodies Product Portfolios and Specifications
Table 99. 3SBio Monoclonal Antibodies Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. 3SBio Main Business
Table 101. 3SBio Latest Developments
Table 102. Accord Healthcare Basic Information, Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors
Table 103. Accord Healthcare Monoclonal Antibodies Product Portfolios and Specifications
Table 104. Accord Healthcare Monoclonal Antibodies Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 105. Accord Healthcare Main Business
Table 106. Accord Healthcare Latest Developments
Table 107. AET Biotech Basic Information, Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors
Table 108. AET Biotech Monoclonal Antibodies Product Portfolios and Specifications
Table 109. AET Biotech Monoclonal Antibodies Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. AET Biotech Main Business
Table 111. AET Biotech Latest Developments
Table 112. Allergan Basic Information, Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors
Table 113. Allergan Monoclonal Antibodies Product Portfolios and Specifications
Table 114. Allergan Monoclonal Antibodies Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 115. Allergan Main Business
Table 116. Allergan Latest Developments
Table 117. Amega Biotech Basic Information, Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors
Table 118. Amega Biotech Monoclonal Antibodies Product Portfolios and Specifications
Table 119. Amega Biotech Monoclonal Antibodies Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 120. Amega Biotech Main Business
Table 121. Amega Biotech Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Monoclonal Antibodies
Figure 2. Monoclonal Antibodies Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Monoclonal Antibodies Sales Growth Rate 2020-2031 (Units)
Figure 7. Global Monoclonal Antibodies Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Monoclonal Antibodies Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Monoclonal Antibodies Sales Market Share by Country/Region (2024)
Figure 10. Monoclonal Antibodies Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Erythropoietin (EPO)
Figure 12. Product Picture of Human Growth Hormone (HGH)
Figure 13. Product Picture of Granulocyte- Colony Stimulating Factor (G-CSF)
Figure 14. Product Picture of Monoclonal Antibody (mAb)
Figure 15. Product Picture of Insulin
Figure 16. Product Picture of Interferon (IFN)
Figure 17. Product Picture of Others
Figure 18. Global Monoclonal Antibodies Sales Market Share by Type in 2025
Figure 19. Global Monoclonal Antibodies Revenue Market Share by Type (2020-2025)
Figure 20. Monoclonal Antibodies Consumed in Anti-Cancer
Figure 21. Global Monoclonal Antibodies Market: Anti-Cancer (2020-2025) & (Units)
Figure 22. Monoclonal Antibodies Consumed in Anti-Inflammatory/Autoimmune
Figure 23. Global Monoclonal Antibodies Market: Anti-Inflammatory/Autoimmune (2020-2025) & (Units)
Figure 24. Global Monoclonal Antibodies Sale Market Share by Application (2024)
Figure 25. Global Monoclonal Antibodies Revenue Market Share by Application in 2025
Figure 26. Monoclonal Antibodies Sales by Company in 2025 (Units)
Figure 27. Global Monoclonal Antibodies Sales Market Share by Company in 2025
Figure 28. Monoclonal Antibodies Revenue by Company in 2025 ($ millions)
Figure 29. Global Monoclonal Antibodies Revenue Market Share by Company in 2025
Figure 30. Global Monoclonal Antibodies Sales Market Share by Geographic Region (2020-2025)
Figure 31. Global Monoclonal Antibodies Revenue Market Share by Geographic Region in 2025
Figure 32. Americas Monoclonal Antibodies Sales 2020-2025 (Units)
Figure 33. Americas Monoclonal Antibodies Revenue 2020-2025 ($ millions)
Figure 34. APAC Monoclonal Antibodies Sales 2020-2025 (Units)
Figure 35. APAC Monoclonal Antibodies Revenue 2020-2025 ($ millions)
Figure 36. Europe Monoclonal Antibodies Sales 2020-2025 (Units)
Figure 37. Europe Monoclonal Antibodies Revenue 2020-2025 ($ millions)
Figure 38. Middle East & Africa Monoclonal Antibodies Sales 2020-2025 (Units)
Figure 39. Middle East & Africa Monoclonal Antibodies Revenue 2020-2025 ($ millions)
Figure 40. Americas Monoclonal Antibodies Sales Market Share by Country in 2025
Figure 41. Americas Monoclonal Antibodies Revenue Market Share by Country (2020-2025)
Figure 42. Americas Monoclonal Antibodies Sales Market Share by Type (2020-2025)
Figure 43. Americas Monoclonal Antibodies Sales Market Share by Application (2020-2025)
Figure 44. United States Monoclonal Antibodies Revenue Growth 2020-2025 ($ millions)
Figure 45. Canada Monoclonal Antibodies Revenue Growth 2020-2025 ($ millions)
Figure 46. Mexico Monoclonal Antibodies Revenue Growth 2020-2025 ($ millions)
Figure 47. Brazil Monoclonal Antibodies Revenue Growth 2020-2025 ($ millions)
Figure 48. APAC Monoclonal Antibodies Sales Market Share by Region in 2025
Figure 49. APAC Monoclonal Antibodies Revenue Market Share by Region (2020-2025)
Figure 50. APAC Monoclonal Antibodies Sales Market Share by Type (2020-2025)
Figure 51. APAC Monoclonal Antibodies Sales Market Share by Application (2020-2025)
Figure 52. China Monoclonal Antibodies Revenue Growth 2020-2025 ($ millions)
Figure 53. Japan Monoclonal Antibodies Revenue Growth 2020-2025 ($ millions)
Figure 54. South Korea Monoclonal Antibodies Revenue Growth 2020-2025 ($ millions)
Figure 55. Southeast Asia Monoclonal Antibodies Revenue Growth 2020-2025 ($ millions)
Figure 56. India Monoclonal Antibodies Revenue Growth 2020-2025 ($ millions)
Figure 57. Australia Monoclonal Antibodies Revenue Growth 2020-2025 ($ millions)
Figure 58. China Taiwan Monoclonal Antibodies Revenue Growth 2020-2025 ($ millions)
Figure 59. Europe Monoclonal Antibodies Sales Market Share by Country in 2025
Figure 60. Europe Monoclonal Antibodies Revenue Market Share by Country (2020-2025)
Figure 61. Europe Monoclonal Antibodies Sales Market Share by Type (2020-2025)
Figure 62. Europe Monoclonal Antibodies Sales Market Share by Application (2020-2025)
Figure 63. Germany Monoclonal Antibodies Revenue Growth 2020-2025 ($ millions)
Figure 64. France Monoclonal Antibodies Revenue Growth 2020-2025 ($ millions)
Figure 65. UK Monoclonal Antibodies Revenue Growth 2020-2025 ($ millions)
Figure 66. Italy Monoclonal Antibodies Revenue Growth 2020-2025 ($ millions)
Figure 67. Russia Monoclonal Antibodies Revenue Growth 2020-2025 ($ millions)
Figure 68. Middle East & Africa Monoclonal Antibodies Sales Market Share by Country (2020-2025)
Figure 69. Middle East & Africa Monoclonal Antibodies Sales Market Share by Type (2020-2025)
Figure 70. Middle East & Africa Monoclonal Antibodies Sales Market Share by Application (2020-2025)
Figure 71. Egypt Monoclonal Antibodies Revenue Growth 2020-2025 ($ millions)
Figure 72. South Africa Monoclonal Antibodies Revenue Growth 2020-2025 ($ millions)
Figure 73. Israel Monoclonal Antibodies Revenue Growth 2020-2025 ($ millions)
Figure 74. Turkey Monoclonal Antibodies Revenue Growth 2020-2025 ($ millions)
Figure 75. GCC Countries Monoclonal Antibodies Revenue Growth 2020-2025 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Monoclonal Antibodies in 2025
Figure 77. Manufacturing Process Analysis of Monoclonal Antibodies
Figure 78. Industry Chain Structure of Monoclonal Antibodies
Figure 79. Channels of Distribution
Figure 80. Global Monoclonal Antibodies Sales Market Forecast by Region (2026-2031)
Figure 81. Global Monoclonal Antibodies Revenue Market Share Forecast by Region (2026-2031)
Figure 82. Global Monoclonal Antibodies Sales Market Share Forecast by Type (2026-2031)
Figure 83. Global Monoclonal Antibodies Revenue Market Share Forecast by Type (2026-2031)
Figure 84. Global Monoclonal Antibodies Sales Market Share Forecast by Application (2026-2031)
Figure 85. Global Monoclonal Antibodies Revenue Market Share Forecast by Application (2026-2031)